Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03931408 · ClinicalTrials.gov registry record · Phase 2
Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
A Phase 2 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT03931408 is a Phase 2 study that has completed, run by University of Louisville. The registered enrollment target is 6 participants.
The verdict
NCT03931408, a Phase 2 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
Participants will undergo daily gentamicin bladder instillations to determine if its use will reduce the rate of symptomatic urinary tract infections (UTIs) as well as the use of oral and intravenous antibiotics in adults with chronic spinal cord injury (SCI) who have recurrent UTIs. Participants are randomized into one of three groups: 1) Gentamicin and saline instillation 2) Saline only instillation 3) Standard of care, no instillation.
Interventions
- DRUG Gentamicin Sulfate
- OTHER Placebo instillation (saline alone)
- OTHER No instillation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-02-19 |
| Est. Completion | 2020-12-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03931408
The ClinicalTrials.gov registry entry for NCT03931408 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Gentamicin Sulfate is the first listed.
NCT03931408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03931408 about?
NCT03931408 is a clinical study titled "Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections". Participants will undergo daily gentamicin bladder instillations to determine if its use will reduce the rate of symptomatic urinary tract infections (UTIs) as well as the use of oral and intravenous antibiotics in adults with chronic spinal cord injury (SCI) who have recurrent UTIs. Participants ar...
What is the current status of trial NCT03931408?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2019-02-19. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT03931408?
The interventions under investigation include: Gentamicin Sulfate (DRUG), Placebo instillation (saline alone) (OTHER), No instillation (OTHER).
Who is sponsoring clinical trial NCT03931408?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.